Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by jojomarchon Jun 10, 2020 12:45pm
131 Views
Post# 31134017

RE:RE:RE:RE:RE:RE:RE:RE:RE:Not Worried About SP...

RE:RE:RE:RE:RE:RE:RE:RE:RE:Not Worried About SP...I blame management when they got the funds from the 44 cents PP in 2015 for not doing a Ph1b in Buffalo, NY at the same time as the Ph1b at Princess Margaret. That would of opened the door to the US/FDA which is the key to many successful biotechs IMO .
Thor6570 wrote:
datawork wrote: There is no restrictions for medical professional crossing the border, that is a non issue. As far as mgmt goes, I think they could have done a few things better. For instance, I think they should have conracted someone who specializes in medical certification process. But to blame mgmt for the trial delay caused by Covid is truly grasping a straws. No one saw this coming and if they had. We wouldn't be here in the first place. If you're unhappy with how things are moving along. Buy some SONA stock and reinvest in TLT three months from now. I'm sure TLT is doing whatever they can to get back on track. Sadly, most of it s out of their control.
Thor6570 wrote: Do not hold your breath on hearing news from US hospitals participation. The border is still not open with restrictions in place on people movement. Reading the news today these restrictions will be extended to late July. We could get our hardware there but training personel I am not so sure. Unless of course our people are traveling for esential medical purposes would need to be designated so , and if this was the case our trial would not have been halted in Canada. While I agree it would be great to here treatment in the US , I would first like to hear that London has actually treated anyone. For the longs you know I have been here since the middle ages hoping and full of excitement at our scientific success. It is my firm belief that our Mgt team needs to be replaced , somthing is wrong at the top or the shoulders. 




Who blamed mgt for covid delays ?


Bullboard Posts